Joint (JYNT) Given Daily Coverage Optimism Score of 0.05

Media stories about Joint (NASDAQ:JYNT) have trended somewhat positive on Monday, Accern Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Joint earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave press coverage about the company an impact score of 44.8285998502101 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Joint (NASDAQ JYNT) opened at $5.00 on Monday. The firm has a market cap of $67.59, a price-to-earnings ratio of -7.35 and a beta of 1.53. Joint has a 1-year low of $2.45 and a 1-year high of $6.00. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.32 and a quick ratio of 1.32.

Joint (NASDAQ:JYNT) last released its quarterly earnings results on Thursday, November 9th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.03. The firm had revenue of $6.55 million for the quarter, compared to analysts’ expectations of $6.28 million. Joint had a negative net margin of 36.74% and a negative return on equity of 98.28%. research analysts expect that Joint will post -0.27 EPS for the current year.

Separately, Zacks Investment Research raised shares of Joint from a “hold” rating to a “buy” rating and set a $5.00 price target on the stock in a report on Wednesday, September 27th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $5.86.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Week Herald and is owned by of Week Herald. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at

About Joint

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Insider Buying and Selling by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with's FREE daily email newsletter.

Leave a Reply